[HTML][HTML] … local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
HJ Burstein, G Curigliano, B Thürlimann, WP Weber… - Annals of oncology, 2021 - Elsevier
… for treatment of early-stage breast cancer. There is increasing recognition that the care of a
… (above), Ki67 assessment will remain a necessary but less proven strategy for determining …
… (above), Ki67 assessment will remain a necessary but less proven strategy for determining …
[HTML][HTML] Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study
I Gómez-Acebo, T Dierssen-Sotos, M Mirones… - Scientific Reports, 2021 - nature.com
… Table 5 Crude Kaplan–Meier estimated survival probabilities according to St Gallen … In
this regard, further St Gallen International Breast Cancer Conferences have focused on a …
this regard, further St Gallen International Breast Cancer Conferences have focused on a …
St. Gallen/Vienna 2021: a brief summary of the consensus discussion on customizing therapies for women with early breast cancer
C Thomssen, M Balic, N Harbeck, M Gnant - Breast Care, 2021 - karger.com
… /Vienna meeting remains the most important international breast cancer meeting on
European soil from a … Estimating the benefits of therapy for early-stage breast cancer: the St. …
European soil from a … Estimating the benefits of therapy for early-stage breast cancer: the St. …
… breast cancer complexity to improve patient outcomes: the St Gallen international consensus conference for the primary therapy of individuals with early breast cancer …
G Curigliano, HJ Burstein, M Gnant, S Loibl… - Annals of …, 2023 - Elsevier
… the St Gallen Consensus Conference aims to offer guidance to clinicians regarding appropriate
treatments for early-stage breast cancer and … can be characterized by determining grade, …
treatments for early-stage breast cancer and … can be characterized by determining grade, …
[HTML][HTML] Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus
H Khaled, YW Nada, KM Ramadan, S Fekry… - … National Cancer …, 2022 - Springer
… Gallen International Breast Cancer Conference 2021 held virtually … Sixty percent of the panel
confirmed that estimation of … in ER-positive and HER2-negative early-stage breast cancer …
confirmed that estimation of … in ER-positive and HER2-negative early-stage breast cancer …
[HTML][HTML] Expert review on systemic treatment in the St. Gallen International Breast Cancer Conference 2021
M Lin, Y Jin, J Zhang - Translational Breast Cancer Research, 2021 - tbcr.amegroups.org
… For the use of immunotherapy in early-stage TNBC, we only have supporting evidence in
neoadjuvant settings so far. Recent clinical trials such as KEYNOTE-522, IMPASSION031, and …
neoadjuvant settings so far. Recent clinical trials such as KEYNOTE-522, IMPASSION031, and …
St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study
U Narbe, PO Bendahl, M Fernö, C Ingvar… - British Journal of …, 2021 - academic.oup.com
… ALN status than those originally included in the Z0011, International Breast Cancer Study
Group 23-01, and AMAROS trials. … Estimating the benefits of therapy for early-stage breast …
Group 23-01, and AMAROS trials. … Estimating the benefits of therapy for early-stage breast …
St. Gallen early breast cancer management recommendations are becoming more applicable to most countries even with different levels of income and healthcare …
H Khaled, YW Nada, KM Ramadan, S Fekry… - 2024 - researchsquare.com
… Gallen International Breast Cancer Conference that was held … has been diagnosed with early
stage breast cancer. They were … assay to help estimate likelihood of recurrence and benefit …
stage breast cancer. They were … assay to help estimate likelihood of recurrence and benefit …
[HTML][HTML] The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time
FAC da Luz, E da Costa Marinho… - …, 2022 - ncbi.nlm.nih.gov
… Breast cancer is a heterogeneous disease with overexpression of several receptors, such …
is a prognostic and predictive biomarker for treatment with the anti-HER2 monoclonal antibody …
is a prognostic and predictive biomarker for treatment with the anti-HER2 monoclonal antibody …
[HTML][HTML] Healthcare use and costs in early breast cancer: a patient-level data analysis according to stage and breast cancer subtype
… aimed to estimate direct medical costs for early breast cancer care in … Estimating the benefits
of therapy for early-stage breast … Gallen international consensus guidelines for the primary …
of therapy for early-stage breast … Gallen international consensus guidelines for the primary …